Wnt/β-catenin, MAPK/ERK, PI3K/AKT and STAT3 signaling are highly activated in glioma, so it is conceivable that simultaneous pharmacological inhibition of all these signaling pathways might be the most effective therapeutic strategy for the prevention and treatment of glioblastoma. This evidence concerns the gene AKT1 and glioma.